首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   661篇
  免费   57篇
  国内免费   1篇
林业   82篇
农学   33篇
基础科学   4篇
  120篇
综合类   42篇
农作物   41篇
水产渔业   86篇
畜牧兽医   194篇
园艺   20篇
植物保护   97篇
  2024年   1篇
  2023年   12篇
  2022年   15篇
  2021年   43篇
  2020年   37篇
  2019年   30篇
  2018年   35篇
  2017年   34篇
  2016年   35篇
  2015年   31篇
  2014年   31篇
  2013年   41篇
  2012年   46篇
  2011年   63篇
  2010年   27篇
  2009年   29篇
  2008年   40篇
  2007年   24篇
  2006年   26篇
  2005年   28篇
  2004年   20篇
  2003年   24篇
  2002年   23篇
  2001年   3篇
  2000年   5篇
  1999年   4篇
  1998年   2篇
  1997年   2篇
  1996年   1篇
  1994年   1篇
  1992年   1篇
  1991年   1篇
  1990年   1篇
  1989年   1篇
  1988年   1篇
  1975年   1篇
排序方式: 共有719条查询结果,搜索用时 15 毫秒
81.
82.
83.
OBJECTIVE: To compare preoperative administration of meloxicam and butorphanol to perioperative administration of butorphanol alone for control of postoperative signs of pain in dogs. ANIMALS: 40 client-owned dogs scheduled for surgical repair of a cranial cruciate ligament rupture. PROCEDURE: Group-1 dogs received butorphanol (0.2 mg/kg, IV) and meloxicam (0.2 mg/kg, IV) just prior to surgery. Group-2 dogs received butorphanol just prior to surgery (0.2 mg/kg, IV) and at incision closure (0.1 mg/kg, IV). Pain assessment began 1 to 2 hours before surgery and from extubation until 24 hours after surgery by obtaining the following measurements: the visual analog scale (VAS) score, cumulative pain score (CPS), adjusted cumulative pain score, modified cumulative pain score, and the adjusted modified cumulative pain score (AMCPS). Serum cortisol concentration was measured between 12 to 24 and between 1 to 2 hours prior to surgery, and at 30 minutes, and 1, 2, 4, 8, 18, and 24 hours after extubation. RESULTS: No significant differences between treatment groups were observed in CPS or VAS score. At 8, 9, 10, and 11 hours after extubation, meloxicam-butorphanol-treated dogs had a significantly lower AMCPS, compared with butorphanol-alone-treated dogs. Total serum cortisol concentration (area under the curve) during the measurement period was significantly lower in meloxicam-butorphanol-treated dogs, compared with butorphanol-alone treated dogs. CONCLUSIONS AND CLINICAL RELEVANCE: Preoperative single dose administration of meloxicam-butorphanol is equivalent to or slightly better than the administration of 2 perioperative doses of butorphanol for the control of postoperative signs of pain in dogs.  相似文献   
84.
85.
Bivalve cultivation, in single cultivation or in polyculture (including integrated multitrophic aquaculture; IMTA), is generally limited to eutrophic waters. We carried out a modeling study to test if, under meso- and oligotrophic conditions, depth could be a key factor for bivalve productivity associated to IMTA and other polyculture strategies. We applied the model Farm Aquaculture Resource Management (FARM) at three strata of the water column in two coastal fish farm areas in the Mediterranean Sea, using water column variables sampled seasonally to estimate the potential mussel production. According to FARM, mussel production was high in both areas and, in some cases, almost doubled when mussels were cultured below 25-m depth compared to shallower levels. Phytoplankton abundance is expected to notably influence mussel production compared to particulate organic matter. Thus, in meso- and oligotrophic stratified waters, where chlorophyll maximum is relatively deep, depth can be a key factor for the productivity of mussel cultivation. The obtained results could help to maximize the production of suspension-feeding bivalve cultivation and, therefore, the expansion and development of sustainable aquaculture in non-eutrophic marine waters.  相似文献   
86.
87.
88.
89.
The aim of this study was to evaluate the effects of a commercially available di-tri-octahedral (DTO) smectite product on clinical signs and prevalence of post-operative diarrhea in horses with colic associated with disease of the large intestine. Sixty-seven horses with surgical disease of the large intestine were randomly assigned to be treated with DTO smectite (n = 37; 0.5 kg via nasogastric intubation every 24 h for 3 days post-operatively) or a placebo (n = 30). The effect of treatment on fecal scores and clinical and hematological parameters, including heart rate, mucous membrane color, temperature, total white blood cell count, total neutrophil count and total plasma protein values, were determined.Horses treated with DTO smectite had a significant reduction in the prevalence of post-operative diarrhea (10.8%), compared with controls (41.4%). A significant improvement in mucous membrane color was observed 72 h post-operatively in horses receiving treatment, compared with placebo. Administration of DTO smectite to colic patients with disease of the large intestine reduced the occurrence of diarrhea in the early post-operative period.  相似文献   
90.
We report the evaluation of the floral origin of honey by analysis of its volatile organic compounds (VOCs) profile, joined with the use of combined pattern recognition techniques. Honey samples, from five floral origins, were analyzed by headspace solid-phase microextraction-gas chromatography-mass spectrometry, selecting 35 VOCs out of the entire profiles, which were analyzed by hierarchical cluster analysis (HCA), stepwise discriminant analysis (SDA), and K-nearest-neighbor (KNN). Both HCA and SDA were used as exploratory tools to select a group of VOCs representing similitude and differences among studied origins. Thus, six out of 35 VOCs were selected, verifying their discriminating power by KNN, which afforded 93% correct classification. Therefore, we drastically reduced the amount of compounds under consideration but kept a good differentiation between floral origins. Selected compounds were identified as octanal, benzeneacetaldehyde, 1-octanol, 2-methoxyphenol, nonanal, and 2-H-1-benzopyran-2-one. The analysis of VOC profiles, coupled to HCA, SDA, and KNN, provides a feasible alternative to evaluate the botanical source of honey.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号